Showing results (1071-1080 of 10,021) with videos related to
Sort By:
Pageof 1,003
Vaccines|February 26, 2022
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the DiseaseLoredana Alessio, Mariantonietta Pisaturo, Antonio Russo, et al.Vaccines|February 26, 2022
COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective StudyHelena Garcia-Llana, Nayara Panizo, Lorena Gandía, et al.Vaccines|February 26, 2022
Capturing a Crucial 'Disorder-to-Order Transition' at the Heart of the Coronavirus Molecular Pathology-Triggered by Highly Persistent, Interchangeable Salt-BridgesSourav Roy, Prithwi Ghosh, Abhirup Bandyopadhyay, et al.Vaccines|February 26, 2022
The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and BeyondDan Gilon, Zaza Iakobishvili, David LeibowitzVaccines|February 26, 2022
Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated?Aniello Maiese, Arianna Baronti, Alice Chiara Manetti, et al.Vaccines|February 26, 2022
Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic ReviewCindra Tri Yuniar, Bhekti Pratiwi, Ardika Fajrul Ihsan, et al.Vaccines|February 26, 2022
Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination StrategiesMatthaios Speletas, Ioanna Voulgaridi, Styliani Sarrou, et al.Vaccines|February 26, 2022
COVID-19 in China and the US: Differences in Hospital Admission Co-Variates and OutcomesYulin Cao, Di Wu, Kuo Zeng, et al.Vaccines|February 26, 2022
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on HemodialysisMichael Jahn, Johannes Korth, Oliver Dorsch, et al.Vaccines|February 26, 2022
Towards a Four-Component GMMA-Based Vaccine against <i>Shigella</i>Francesca Micoli, Usman N Nakakana, Francesco Berlanda ScorzaPageof 1,003